Plain-English translation of NCT06979453 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called in teenagers with moderate to severe plaque psoriasis. About 366 teenagers will be randomly assigned to receive either the medication or a placebo (a dummy pill that looks identical), and neither the participants nor the doctors will know who gets which. Researchers want to see if the medication is safe, effective, and how the body processes it.
Plaque psoriasis can be uncomfortable and impact quality of life for teenagers, and current treatment options aren't effective enough for everyone. This trial is testing whether this new medication could offer teenagers with moderate to severe psoriasis a better treatment choice.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to take either the new medication or a placebo by mouth. You will have multiple visits with the research team to check how well the treatment is working, have blood tests to measure drug levels, and answer questions about your psoriasis symptoms. The study will last several months, and you'll need to keep track of how your skin responds to the treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States